Amiel Mathes

The iQ Group Global

At The iQ Group Global, we are a diverse team of experts who work together to find, fund and develop bioscience discoveries into life-changing medical innovations – and take them to the people who need them most. Our scientific team identifies bioscience discoveries from laboratories all over the world that have potential life-changing impact. Our corporate advisory and investment banking teams work together to translate scientific milestones into value creation events, creating financial instruments and corporate structures that activate commercial value. Our commercialization team partners with healthcare providers and unlocks regulatory pathways to take the discovery to the people who need it. The iQ Group Global companies: The iQ Group Global Ltd. (formerly iQnovate) (IQN: NSX) Bridging science with business iQ3Corp. Ltd (iQ3: ASX) Translating science into capital and beyond iQX Investments Ltd (iQX: NSX) Eradicating disease through capital investment iQDex iQDex Life Sciences Index Clinical Research Corporation (CRC) Pty Ltd Redefining Medical Affairs FarmaForce Ltd (FFC:ASX) Your force in healthcare iQ Capital Inc Our New York-based investment bank, investing in the medicines of the future iQBiosensor Saliva: The future of glucose monitoring Capital Labs A new era in start-up venture funding